CD8A and neoplasm: Further, we determined the percentage of CD8+ T cells of the totalCD3+ and CD45+ cells in the tumor microenvironment in the PCaA-SEVvaccinated group of mice, 3 weeks after tumor inoculation (Figure 6A).